EPATOX TRANSITION: NUTRITIONAL SOLUTION FOR STEAMING UP PERIOD THAT PREVENTS AND MANAGES KETOSIS IN DAIRY COWS WITH INNOVATIVE APPROACH

Genetic selection and dairy cow production increase that has been going on for at least 25 years, have led to a pathology known since the 1990s, identified by the acronym NEB (negative energy balance). Today, the “genetically selected” dairy cow produces more than ingestion allows, forcing it to drain from its lipid and muscle reserves available sources of energy and amino acids essential for production.

Therefore, it is NOT possible to consider lipomobilisation a real pathology, but a metabolic necessity that we have induced and that we must get used to managing.

Among the various blood markers to be subjected to analysis, we have to avoid considering ketosis in a dogmatic and absolute way; NEFA undisputedly represent the lipids mobilized for energy purposes quote, while ketone bodies are the final outcome of a varied and complex metabolic chain.

We begin to consider lipid metabolism as a chain in which there may be “weak” links to be supported with correct integration in order not to induce hepatic oxidation phenomena with its often harmful consequences; in this perspective, the correlation between NEFA and integration becomes a managerial key and metabolic factor which will manifest itself with an increase in dairy cows health during transition phase.

The goal is not to look for a low incidence of NEFA or BHBA in immediate postpartum period, but to help to make the liver able to metabolize these lipids without inducing hepatic suffering and related pathologies.

GRANDA TEAM’S RESPONSE WITH TRANSIZIONE 4.0 PROGRAM

It is possible to face peripartum period while managing to achieve excellent production performances as well as a very low incidence of metabolic pathologies through a new herd approach during transition period (NMA® NEB Management approach by Granda Team Transizione 4.0) and with a specific solution use (Epatox Transition solution designed and produced by Granda Team), applied to dairy cows affected by NEB and with high blood NEFA and BHBA values.

Lipid mobilization is an extremely punctual datum, variable in very short times, but above all not correlated between prepartum analyzes and postpartum analyses; finding low levels of NEFA in prepartum (< 0.4 mmol/L) does not guarantee the presence of low levels of NEFA even in the postpartum phase. It is evident that the datum to be absolutely taken into consideration consists both of sampling time (pre and post calving days) and of  marker considered type.

According to Granda Team TRANSITION 4.0 protocol, the true lipomobilisation marker is represented by NEFAs determined in postpartum phase and therefore herd screening should be set up and dedicated to the determination of these rather than spending time and money on the others indirect and not directly related markers determination.

Use a specific technological solution (EPATOX TRANSITION), administered to the entire herd during transition phase, which contains all the necessary precursors for NEFA metabolic use for energy purposes.

This integrative solution use allows the treated cows to perform optimally both in terms of postpartum pathologies incidence and in terms of subsequent lactation production while showing high blood NEFA and BHBA values.

KEY POINTS TO FOLLOW IN KETOSIS MANAGING WITH GRANDA TEAM’S TRANSITION 4.0 PROTOCOL: